h i g h l i g h t s g r a p h i c a l a b s t r a c t

a b s t r a c t
The development of novel drugs for the treatment of leishmaniases continues to be crucial to overcome the severe impacts of these diseases on human and animal health. Several bioactivities have been described in extracts from macroalgae belonging to the Cystoseira genus. However, none of the studies has reported the chemical compounds responsible for the antileishmanial activity observed upon incubation of the parasite with the aforementioned extracts. Thus, this work aimed to isolate and characterize the molecules present in a hexane extract of Cystoseira baccata that was found to be bioactive against Leishmania infantum in a previous screening effort. A bioactivity-guided fractionation of the C. baccata extract was carried out and the inhibitory potential of the isolated compounds was evaluated via the MTT assay against promastigotes and murine macrophages as well as direct counting against intracellular amastigotes. Moreover, the promastigote ultrastructure, DNA fragmentation and changes in the mitochondrial potential were assessed to unravel their mechanism of action. In this process, two antileishmanial meroditerpenoids, (3R)-and (3S)-tetraprenyltoluquinol (1a/1b) and (3R)-and (3S)-
Introduction
Leishmaniases are a group of infectious diseases caused by obligate intracellular protozoa of the Leishmania genus. Endemic in 98 tropical and subtropical countries and affecting 12 million people, leishmaniases may entail cutaneous, mucocutaneous and diffuse forms as well as the potentially fatal visceral form (Alvar et al., 2012) . Visceral leishmaniasis causes considerable morbidity in 200e400 thousand individuals every year, with extreme suffering and financial loss, especially in the poorest populations of the Indian subcontinent (Mondal et al., 2014) . Currently, leishmaniases are among the most neglected tropical diseases, facing problems of resistance of the parasite to the available therapeutic molecules. The need for the discovery and development of alternative drugs allowing more efficient and effective treatments is thus quite urgent (Freitas-Junior et al., 2012) .
Nowadays, marine natural products are recognized as powerful reservoirs of novel, chemically diverse molecules with wide applicability to health sciences (Tempone et al., 2011) . Occurring worldwide, mainly in the rocky substrates of the Mediterranean Sea and the adjoining Atlantic coasts, Cystoseira C. Agardh (1820) genus encompasses approximately 40 species of brown macroalgae (Guiry and Guiry, 2015) . Several bioactivities such as antiinflammatory, antiproliferative, antioxidant (Mhadhebi et al., 2011) , enzyme inhibitory (Ghannadi et al., 2013) , cytotoxic (Khanavi et al., 2010) , antifungal (Lopes et al., 2013) , antiviral (Ibraheem et al., 2012) , antibacterial (Tajbakhsh et al., 2011) and antiprotozoal (Spavieri et al., 2010) have been detected in this algal genus. Despite the extensive chemical studies available for the Cystoseira genus, there have been only a few reports describing the antileishmanial potential effects of its crude extracts, and no information was found on the compounds responsible for the inhibitory effects on the Leishmania parasites (Amico, 1995; de Los Reyes et al., 2012) . As part of ongoing research on the identification of antileishmanial compounds from the Cystoseira genus, this work describes the bioactivity-guided fractionation of the hexane extract from Cystoseira baccata and the effect of the extract, fractions and isolated compounds on the promastigote and amastigote forms of Leishmania infantum.
Material and methods
General experimental procedures
Optical rotations were measured in a JASCO DIP-370 digital polarimeter (Na filter, l ¼ 588 nm). UV spectra were recorded using a UV/visible Shimadzu 1650-PC spectrophotometer. IR spectra were obtained with a Shimadzu IR Prestige-21 spectrophotometer. 
Extraction and isolation of compounds
Dried and powdered biomass (120 g) was exhaustively extracted with hexane in a Soxhlet apparatus. After evaporation of the solvent under reduced pressure, 1.3 g of crude extract were obtained. Part of this extract (0.6 g) was subject to column chromatography over SiO 2 eluted with hexane containing increasing amounts of EtOAc (up to 100%), followed with CHCl 3 containing increasing amounts of MeOH (up to 100%), generating 13 fractions (1e13). As fraction 10 (370.0 mg) displayed activity towards promastigote forms of L infantum, it was fractionated over SiO 2 column, and eluted with hexane:EtOAc 1:1 yielding 6 sub-fractions (A e F). Bioactive sub-fraction E (195 mg) was purified in a Sephadex LH-20 column being eluted with hexane:CH 2 Cl 2 1:4, CH 2 Cl 2 :Me 2 CO 3:2 and 1:1 (Cardellina, 1983) originating 4 groups (E1 e E4). Bioactive group E4 (65.3 mg) was subjected to preparative TLC (hexaneEtOAc, 7:3, twice) to afford compounds 1a/1b (23.2 mg; 0.30%) and 2a/2b (2.5 mg; 0.04%) (Fig. 1) .
3R e tetraprenyltoluquinol (1a) and 3S e tetraprenyltoluquinol (1b). Yellowish oil;
1 H NMR and 13 C NMR (500 MHz, CDCl 3 ) data, see Nova de Lisboa, Portugal) and cultivated in M199 medium supplemented with 10% foetal bovine serum (FBS), penicillin (10 U/L), streptomycin (0.01 mg/L) and 2% of human male urine at 25 C. Peritoneal macrophages from BALB/c mice were cultivated in RPMI-1640 medium supplemented with 10% FBS, Lglutamine (2 mM), penicillin (50 U/L) and streptomycin (0.05 mg/L) at 37 C in humidified atmosphere with 5% CO 2 . BALB/c mice were obtained in the Animal Facility of the School of Medicine of São Paulo University e Brazil. These animals were maintained in accordance with the institutional guidelines regarding the welfare of experimental animals and with the approval of the Animal Ethics Committee of São Paulo University (322/12).
Activity against Leishmania promastigotes
For the determination of the antileishmanial activity, L. infantum promastigotes in stationary phase (2 Â 10 6 parasites/mL) were incubated with the hexane extract at a concentration of 250 mg/mL for 24 h on 96-well plates. Using the same methodology, the fractions obtained during the bioactivity-guided fractionation were tested at a concentration of 50 mg/mL. At a later stage, compounds 1 and 2 were added at concentrations ranging from 0.9 to 227.0 and 0.9 to220.0 mM, respectively. Parasites treated with miltefosine at the half maximal inhibitory concentration (IC 50 ¼ 23.1 mM) were used as positive control. Promastigotes incubated with M199 medium were used as negative control. Parasite viability was determined by the MTT colorimetric assay (Dutta et al., 2005; Dal Picolo et al., 2014) . Briefly, after incubation plates were centrifuged at 10 C, using an RCF of 1479 Â g for 10 min, washed three times with PBS, and supernatants discarded. Afterwards, 50 mL of MTT (5 mg/ mL in PBS) were added to each well and plates were re-incubated at 37 C for 2 h. Upon incubation, 50 mL of SDS were added to each well and plates were incubated for 18 h in order to dissolve the formazan crystals. Absorbance was measured at 590 nm using a Thermo Scientific Multiskan™ FC Microplate Photometer. Results were expressed in terms of parasite viability (%) relative to nontreated parasites and the half maximal inhibitory concentration (IC 50 ; mM).
Ultrastructural alterations of the promastigotes
L. infantum promastigotes in stationary phase (2 Â 10 6 cells/mL) were incubated at 25 C for 24 h on 96-well plates with compounds 1 and 2 at their IC 50 values, i.e. 44.9 mM of 94.4 mM, respectively.
Non-treated promastigotes were used as negative control. After incubation, the plate was centrifuged at 1479 Â g for 10 min at 4 C, and washed with PBS three times. Pellets were fixed in 0.1% tannic acid dissolved in 2.0% glutaraldehyde in a 0.15 M phosphate buffer pH 7.2 and incubated for 1 h at 4 C. These were afterwards contrasted in 1% osmium tetroxide and a 0.5% uranyl acetate solution for 12 h; then the samples were embedded in araldite resin (Yamamoto et al., 2015) . Ultrathin sections (70 nm), obtained with an ultramicrotome Reichert and double contrasted with 2% uranyl acetate and 0.5% lead citrate, were examined using a JEOL 1010 transmission electron microscope.
Promastigotes DNA integrity
To detect whether the compounds induced fragmentation on L. infantum nuclear DNA, promastigote forms in stationary phase of growth (2 Â 10 8 cells) were incubated with IC 50 concentrations of Fig. 1 . Structures of the tetraprenyltoluquinols (1a-1b) and tetraprenyltoluquinones (2a-2b) isolated from C. baccata.
compounds 1 (44.9 mM), 2 (94.4 mM) and hydrogen peroxide (6.2 mM) as an inductor of DNA damage in parasites (Das et al., 2001) for 24 h at 25 C. Non-treated cells were used as control. After incubation, plates were centrifuged at 1479 Â g for 10 min at 4 C, and the supernatants discarded. Parasites pellets were extracted with a Macherey-Nagel nucleoSpin ® Blood kit according with the manufacturer recommendations and ran on a 2% agarose gel, 100 V for 90 min.
Promastigote transmembrane mitochondrial potential
In order to evaluate the influence of compound 1 on the promastigote mitochondrial membrane potential (DJm), parasites in the stationary phase (2 Â 10 6 parasites/mL) were incubated with compound 1 and miltefosine at their IC 50 values (44.9 and 23.1 mM, respectively) for 24 h on 96-well plates. Mitochondrial membrane potential was evaluated using the widefield automated microscope Mitoscreen Kit (BD Biosciences) according to the manufacturer's recommendations (Levy et al., 2014; Yamamoto et al., 2015) . Briefly, cells were incubated with working solution, containing the JC-1 (5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolylcarbocyanine iodide) fluorochrome, for 15 min at 37 C in an atmosphere of 5% 
Cytotoxicity against murine macrophages
To determine the compounds toxicity in vitro, murine peritoneal macrophages, were seeded in RPMI-1640 at a density of 10 6 cells/ mL and incubated overnight at 37 C in humidified atmosphere with 5% CO 2 , allowing the cells to adhere to the plate background.
Compounds 1 and 2 were tested for 24 h at concentrations ranging from 0.9 to 227.0 and 0.9e220.0 mM, respectively. Miltefosine control cells were incubated with RPMI-1640 medium at concentrations from 3.8 up to 490.7 mM. Cell viability was evaluated by the MTT colorimetric assay (Ferrari et al., 1990; Dal Picolo et al., 2014) , as described above, for the determination of the activity against Leishmania promastigotes. Absorbance was measured at 590 nm using a Thermo Scientific Multiskan™ FC Microplate Photometer.
Results were expressed in terms of the cytotoxic concentration Fig. 2 . HMBC of the tetraprenyltoluquinones (2a-2b) isolated from C. baccata.
causing a 50% decrease in cell viability (CC 50 ; mM) relative to nontreated cells (100%).
Activity against Leishmania intracellular amastigotes and NO production
Peritoneal macrophages of BALB/c mice were collected by intraperitoneal lavage, seeded on 24-well plates (10 5 cells/mL) and incubated at 37 C with 5% CO 2 during 2 h for cell attachment. Afterwards, L. infantum promastigotes in stationary phase were added to each well at an infection ratio of 10 promastigotes per cell, being further incubated at 37 C for 24 h. Infected macrophages were treated with compounds 1 and 2 at concentrations ranging from 7 to 90 mM to determine the corresponding IC 50 . Supernatants were collected for nitric oxide (NO) determination after 24 h and intracellular amastigote burden was microscopically assessed upon Giemsa staining for determination of the infection index [% of infected macrophages Â internalized amastigote forms/macrophage)] and the inhibitory concentration allowing 50% reduction of the infection index (IC 50 ) was estimated. Miltefosine was used as positive control. Culture supernatants of treated and control macrophages were used for NO determination that was performed using the Measure-iT™ High-Sensitivity Nitrite Assay Kit in accordance with the manufacturer's recommendations (Life Technologies). The NO concentration was determined using a calibration curve prepared with several known concentrations (2.75, 5.5, 11, 22, 33, 44 and 55 mM) of nitrite as standard. Results were expressed as NO production (mM) and compared with untreated infected and non-infected macrophages. The selectivity index (SI) was obtained by calculating the ratio of the CC 50 of the macrophage by the IC 50 of the intracellular amastigotes.
Statistical analysis
Bioassays results were expressed as mean ± standard error of the mean (SEM) of replicates samples from at least two independent assays. The IC 50 values were calculated fitting the data as a non-linear regression using a dose-response inhibitory model, in the GraphPad Prism V 5.0 program. Student's t-test was used to determine whether differences between means were significant at different levels (p < 0.05 and p < 0.01).
Results and discussion
The hexane extract from the C. baccata was incubated with promastigote forms of L. infantum for 24 h, and cell viability was determined by means of the MTT assay. As this extract decreased the viability of the parasite by 74% at a concentration of 250 mg/mL, it was selected for further study. Bioactivity-guided fractionation afforded compounds 1 and 2 (Fig. 1) (1a) and (3S)- (1b) tetraprenyltoluquinol, previously isolated from C. baccata (Valls et al., 1993) . In addition, some corrections in the attributions of chemical shifts of C-18 and C-19 in 13 C NMR spectrum were carried out, based on the HMBC spectral analysis ( 133.5/134.0 (C-13) indicated that compound 2 contained one additional carbonyl group at C-1. Based on these results, it was possible to identify 2 as epimers of (3R)- (2a) and (3S)- (2b) tetraprenyltoluquinones.
In vitro antiparasitic activity and cytotoxic studies of the compounds 1 and 2 were evaluated by the colorimetric MTT method against promastigote forms of L. infantum and murine macrophages, respectively (Table 2) . Compound 1 displayed an IC 50 value of 44.9 ± 4.3 mM against promastigote forms of L. infantum. The cytotoxicity against mouse peritoneal macrophages (CC 50 ¼ 126.6 ± 21.1 mM) was similar to that of the reference drug, miltefosine (130.3 ± 17.2 mM). Compound 2 showed lower activity against the promastigote forms (IC 50 ¼ 94.4 ± 10.1 mM), and higher toxicity to the mouse peritoneal macrophages (CC 50 ¼ 84.5 ± 12.5 mM).
To assess the alterations induced by the compounds on the promastigotes forms of L. infantum, transmission electron microscopy images were acquired (Fig. 3) . Important changes were observed with both treatments, including loss of the typical fusiform shape (Fig. 3A) . Ultrastructural analysis revealed morphologic changes in parasites treated with the IC 50 concentrations of both compounds 1 (Fig. 3B and C) and 2 ( Fig. 3D and E) . Moreover, cellular vacuolization was observed, which might be a consequence of cytoplasmic organelle disruption (Fig. 3B and D) . When treated with compound 1, parasites presented coiled multilamellar structures within the mitochondria (Fig. 3C ). These structures have been shown to be a consequence of starvation processes caused by deficient mitochondrial activity or autophagic mechanisms caused c SI e Selectivity index concerning the activity against the intracellular amastigotes.
by the action of chemical compounds on these organelles (Lockshin and Zakeri, 2004) . If left unchecked, both processes may result in the removal of the damaged organelles as well as cell death (Nishikawa et al., 2010 ). Previous studies have described similar structures in promastigotes of different Leishmania species treated with distinct natural products (Monte Neto et al., 2011) . Compound 2 induced noticeable changes in the ultrastructure of the cell, in particular the occurrence of pyknotic nuclei, which was accompanied by the disappearance of the chromatin associated with the nuclear inner membrane (Fig. 3D) . Overall, these compounds seem to induce parasite death through different mechanisms. Other reports have shown that Leishmania apoptosis occurs in response to different drugs (Holzmuller et al., 2002) . In order to evaluate if the alterations observed in the nuclei were associated with DNA fragmentation and consequently with programmed cell death, promastigote DNA was analysed through horizontal electrophoresis. This analysis did not reveal any fragmentation of the genomic DNA when promastigote forms of L. infantum were treated with the IC 50 concentrations of compounds 1 and 2 (Fig. 4A) , suggesting that the observed cytotoxic effect might not be associated with programmed cell death. Although chromatin condensation culminating in nucleolytic pyknosis is usually accompanied by macronuclear DNA digestion, generating oligonucleosomal fragments of low molecular weight (Kobayashi and Endoh, 2003) , non-nucleolytic pyknotic processes have also been described previously (Burgoyne, 1999) .
As Leishmania cells have a single mitochondrion, the proper functioning of mitochondria, including the stability of their membrane potential, is vital for the survival of the parasite. This organelle is usually considered as a good indicator of cellular dysfunction and therefore is an interesting target for chemotherapeutic studies (Souza et al., 2009) . Because the variation of the mitochondrial membrane potential (DJm) in different Leishmania species exposed to various drugs has been reported (Britta et al., 2014) and that changes were observed in the morphology of the mitochondria of promastigotes treated with compound 1, the DJm in cells incubated with the latter chemical was evaluated. This was carried out in order to elucidate possible mechanisms of cell death induced by the compound displaying the most potent activity against L. infantum promastigotes. This parameter was determined by assessing the presence of JC-1 fluorochrome inside the mitochondria using a widefield automated microscope. DJm induces the uptake of JC-1 monomers into the functional mitochondria. Once inside the organelle, JC-1 monomers aggregate, exhibiting high levels of red fluorescence. At the IC 50 , compound 1 induced a significant (p 0.01) decrease in fluorescence-emitting cells (133.3 ± 8.5 J-aggregates/well) as compared to non-treated (762.5 ± 36.7 J-aggregates/well) promastigotes (Fig. 4B) , corresponding to a disruption of 83% of the DJm. This effect was higher than that observed with miltefosine (216.0 ± 22.6 J-aggregates/ well), which disrupted the DJm by only 72%. Interestingly, similar drops in DJm coupled with changes in the mitochondrial against the peritoneal macrophages ( Fig. 5A ; Table 2 ). Only five compounds isolated from marine algae with antileishmanial activity have been reported previously (da Silva Machado et al., 2011; dos Santos et al., 2010 dos Santos et al., , 2011 Soares et al., 2012) . However, none of the studies was about Cystoseira macroalgae. Reported sesquiterpenes obtusol (IC 50 ¼ 9.4 mM; da Silva Machado et al., 2011) and elatol (IC 50 ¼ 13.5 mM and 0.45 mM) from the red alga Laurencia dendroidea (da Silva Machado et al., 2011; dos Santos et al., 2010) showed strong activity against L. amazonensis intracellular amastigotes. However, the triquinane sesquiterpene isolated from the same algae was significantly less effective (IC 50 ¼ 217.4 mM; da Silva Machado et al., 2011) . In addition, 4-acetoxydolastane and dolabelladienetriol, isolated from the brown alga Canistrocarpus cervicornis (IC 50 ¼ 12.3 mM; dos Santos et al., 2011) and Dictyota pfaffii (IC 50 ¼ 44.0 mM; Soares et al., 2012) , respectively, were also tested against the same species and form of Leishmania. Therefore, the activity of compound 1 was in the range of that reported for the aforementioned diterpenes.
Despite the lower activity of compound 2 against promastigotes (IC 50 ¼ 94.4 ± 10.1), it was higher than the effect reported for triquinane (IC 50 ¼ 195.5 mM) on promastigotes. However, similarly to what has been reported for triquinane (da Silva Machado et al., 2011) , the treatment with the tetraprenyltoluquinone (2) did not decrease the infection index (Fig. 5A) .
During the infection by Leishmania, NO is released by macrophages to eliminate intracellular amastigotes (reviewed by de Almeida et al., 2003) . In addition, NO production can be triggered by natural compounds, including those from algae (Robertson et al., 2015) . In the present study, infected peritoneal macrophages treated with compounds 1 and 2 produced low or undetectable amounts of NO as compared to controls. The NO released when the lowest concentrations (8.4 and 17 mM) were applied to the cells was residual, suggesting that the leishmanicidal effect observed for 1 was not related to NO production by the host macrophages (Fig. 5B ) and that these compounds did not display an immunomodulatory effect. These results are in agreement with da Silva Machado et al. (2011) who observed that triquinane, elatol and obtusol did not promote enhanced NO levels, indicating that leishmanicidal effect of these compounds might be mediated by a mechanism that does not involve the release of this signalling molecule by the host cell. were treated with 1a/1b (44.9 mM) and 2a/2b (94.4 mM). Hydrogen peroxide (6.2 mM) (A) and miltefosine (23.1 mM) (B) and untreated parasites (A and B) were used as controls. *, p < 0.05; **, p < 0.01. Fig. 5 . Effect of compounds 1 and 2 on the L. infantum intracellular amastigotes (A) and on the nitric oxide production (mM) of the infected mouse peritoneal macrophages (B) after a 24-h treatment with different concentrations (mM). Untreated non-infected macrophages (CTLþ), untreated infected macrophages (CTL inf) and infected macrophages treated with a reference drug, miltefosine, were used as controls.
In conclusion, this is the first report describing the identification of compounds from Cystoseira macroalgae displaying activity against Leishmania parasites. In addition, the isolation of tetraprenyltoluquinone (2) as a novel metabolite from algae of the Cystoseira genus is described. Concerning the particular chemical structure of these compounds, our data suggest that the presence of the carbonyl group in C-1 could play a role in the antileishmanial activity of the compounds 1 and 2. Although not as active as miltefosine, tetraprenyltoluquinol (1) displayed significant antileishmanial activity and could be considered as an interesting scaffold for the development of novel chemotherapeutic molecules for canine and human visceral leishmaniases studies. Furthermore, this work reinforces the evidence of the marine environment as source of novel molecules.
